Summary of Publications

  n Impact faktor 2015
original publications 32 89,998
Reviews 11 18,625
Total publications 43 108,623
  n Impact faktor 2015
original publications 17 26,402
Reviews 6 3,977
Total publications 23 30,379

Publications Страница 2 из 4


42. Neonatal blood rheological parameters at delivery in healthy neonates and in those with morbidities.
2013 Mar 26. [in press] PMID: 23532177. Clin Hemorheol Microcirc. 0
A.A. Soliman, R. Csorba, P. Tsikouras, C. Wieg, H. Harnack, G.-F.v. Tempelhoff.

41. Pregnancies and their obstetric outcome in two selected age groups of teenage women in Greece.
2012;25:1606-11. J Matern Fetal Neonatal Med. 1.518
P. Tsikouras, A. Dafopoulos, G. Trypsianis, N. Vrachnis, S. Bouchlariotou, S.A.Liatsikos, K. Dafopoulos, G. Maroulis, G. Galazios G, A.T. Teichmann, G.-F.v. Tempelhoff.

40. Low-molecular-weight heparin versus placebo for the prevention of venous thromboembolism in metastatic breast cancer or stage III/IV lung cancer.
2012;18:159-65. Clin Appl Thromb Hemost. 1.016
S.K. Haas, M. Freund, D. Heigener, L. Heilmann, B. Kemkes-Matthe, G.-F.v. Tempelhoff , N. Melzer, A.K. Kakkar, TOPIC Investigators.

39. Blood rheology at term in women with normal and complicated pregnancy.
2009;42:127-39. Clin Hemorheol Microcirc. 3.398
G.-F.v. Tempelhoff, L. Heilmann, E. Velten, P. Freund, J. Koscielny.

38. Mean maternal 2nd trimester hemoglobin-concentration and outcome of pregnancy – A population based Study.
2008;14:19-28. Clin Appl Thromb Hemost. 1.016
G.-F.v. Tempelhoff, L. Heilmann, L. Rudig, C. Wildt, K. Pollow, G. Hommel, J. Koscielny.

37. Preoperative identification of patients with impaired (primary) hemostasis - a practical concept.
2007;27:177-84. Hamostaseologie. 1.190
J. Koscielny, S. Ziemer, H. Radtke, M. Schmutzler, H. Kiesewetter, A. Salama, G.-F v. Tempelhoff.

36. More on: platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function.
2006;4:1426-7. J Thromb Haemost. 6.081
J. Koscielny, H. Kiesewetter, G.-F.v. Tempelhoff.

35. Monitoring of rheological variables during post operative high dose brachytherapy for uterine cancer.
2004;10:239-48. Clin Appl Thromb Hemost. 1.332
G.-F.v. Tempelhoff, L. Heilmann, K. Pollow, G. Hommel.

34. A practical concept for preoperative management of patients with impaired primary hemostasis.
2004;10:155-66. Clin Appl Thromb Hemost. 1.332
J. Koscielny ,G.-F.v. Tempelhoff, S. Ziemer, H. Radtke, M. Schmutzler, P. Sinha, A. Salama.

33. ProC® Global Assay in the evaluation of women with history of severe preeclampsia or HELLP Syndrome.
2002;8:319-24. Clin Appl Thromb Hemost. 1.332
L. Heilmann, G.-F.v. Tempelhoff, K. Pollow.

32. Thrombosis - A clue of poor prognosis in primary non-metastatic Breast Cancer.
2002;73:275-7. Breast Cancer Res Treat. 4.431
G.-F.v. Tempelhoff, L. Heilmann, G. Hommel.

31. Soluble Urokinase Plasminogen Activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological cancer.
2001;82:523-31. Gynecol Oncol. 3.888
R. Riisbro, R.W. Stephens, N. Brünner, L.J. Christensen, H.J. Nielsen, L. Heilmann, G.-F. v. Tempelhoff.

30. Tumor Hypoxia, the physiological link between Trousseaus’s Syndrome (Carcinoma induced Coagulopathy) and Metastasis.
2001;61:7697-8. Cancer Res. 7.856
G.-F.v. Tempelhoff, L. Heilmann, G. Hommel.

29. The role of intravenous volume expansion in moderate pre-eclampsia.
2001;25:83-9. Clin Hemorheol Microcirc. 3.398
L. Heilmann, S. Gerhold, G.-F.v. Tempelhoff, K. Pollow.

28. The influence of antiphospholipid antibodies on the pregnancy outcome of patients with recurrent spontaneous abortion.
2001;7:281-5. Clin Appl Thromb Hemost. 1.332
L. Heilmann, G.-F.v. Tempelhoff, S. Kuse.


Copyright © 2024 - KIWU - von Tempelhoff

We use cookies

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.